Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INMB | AMGN | VRTX | BMY | REGN |
| Company | Inmune Bio Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 11.17 | 313.39 | 401.50 | 43.90 | 926.94 |
| High | 11.75 | 322.60 | 405.67 | 44.33 | 951.91 |
| Low | 11.12 | 310.65 | 397.59 | 43.69 | 926.94 |
| Last | 11.61 | 312.81 | 401.64 | 43.88 | 952.06 |
| Change | +0.48 | +34.42 | +1.48 | +0.18 | +14.45 |
| % Change | +4.31% | +12.36% | +0.37% | +0.41% | +1.54% |
| Volume | 73,435 | 7,238,597 | 533,576 | 7,023,680 | 223,814 |
| 20-Day Average Volume | 175,576 | 2,518,276 | 994,469 | 14,172,068 | 502,036 |
| Previous Close | 11.13 | 278.39 | 400.16 | 43.70 | 937.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.45 | 272.29 | 398.48 | 47.46 | 909.54 |
| 20-Day Raw Stochastic | 76.24% | 82.48% | 68.95% | 6.43% | 98.06% |
| 20-Day Relative Strength | 54.19% | 72.26% | 47.91% | 28.52% | 57.54% |
| Weighted Alpha | +17.59 | +34.02 | +14.72 | -36.91 | +25.52 |
| Today's Opinion | 48% Buy | 24% Buy | 8% Buy | 100% Sell | 72% Buy |
| Previous Opinion | 16% Buy | 16% Sell | 8% Buy | 88% Sell | 48% Buy |
| Last Month's Opinion | 24% Buy | 24% Sell | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.37% since 04/26/24 | +15.47% since 04/26/24 | +1.14% since 04/26/24 | -2.19% since 04/26/24 | +7.61% since 04/26/24 |
| Low | 10.81 on 05/02/24 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 43.33 on 05/02/24 | 883.20 on 04/29/24 |
| High | 12.72 on 04/30/24 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 951.91 on 05/03/24 |
| 1-Month | |||||
| %Chg | +15.54% since 04/03/24 | +13.60% since 04/03/24 | -1.67% since 04/03/24 | -15.93% since 04/03/24 | -0.06% since 04/03/24 |
| Low | 8.30 on 04/19/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 12.72 on 04/30/24 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 52.08 on 04/04/24 | 962.20 on 04/04/24 |
| 3-Month | |||||
| %Chg | +5.32% since 02/02/24 | -3.54% since 02/02/24 | -5.34% since 02/02/24 | -9.94% since 02/02/24 | +0.55% since 02/02/24 |
| Low | 8.30 on 04/19/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 14.74 on 02/14/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +61.63% since 11/03/23 | +15.52% since 11/03/23 | +6.86% since 11/03/23 | -16.94% since 11/03/23 | +16.35% since 11/03/23 |
| Low | 6.63 on 11/13/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.33 on 05/02/24 | 783.57 on 11/10/23 |
| High | 14.74 on 02/14/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 202,599 | 149,321,728 | 103,424,960 | 88,584,272 | 102,913,952 |
| Shares Outstanding, K | 18,203 | 536,376 | 258,459 | 2,027,100 | 109,762 |
| Annual Sales | 160,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 13,117,200,000 |
| Annual Net Income | -30,010,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 3,953,600,000 |
| Last Quarter Sales | 30,000 | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -8,410,000 | 767,000,000 | 968,800,000 | -11,911,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.92 | 0.60 | 0.39 | 0.45 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.47 on 03/28/24 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 05/06/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 04/04/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 42.10 | 24.04 |